Peginesatide for Anemia in Chronic Hemodialysis Patients
Public ClinicalTrials.gov record NCT00228449. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Open-label, Multi-center, Sequential, Dose Finding Study of the Safety, Pharmacodynamics, and Pharmacokinetics of Peginesatide Administered Intravenously for the Maintenance Treatment of Anemia in Chronic Hemodialysis Patients
Study identification
- NCT ID
- NCT00228449
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Affymax
- Industry
- Enrollment
- 165 participants
Conditions and interventions
Conditions
Interventions
- peginesatide Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2005
- Primary completion
- Apr 30, 2007
- Completion
- Apr 30, 2007
- Last update posted
- Dec 20, 2012
2005 – 2007
United States locations
- U.S. sites
- 14
- U.S. states
- 12
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Facility | Birmingham | Alabama | 35213 | — |
| Research Facility | Pine Bluff | Arkansas | 71603 | — |
| Research Facility | Los Angeles | California | 90095 | — |
| Research Facility | Mountain View | California | 94041 | — |
| Research Facility | Lauderdale Lakes | Florida | 33313 | — |
| Research Facility | Pembroke Pines | Florida | 33028 | — |
| Research Facility | Shreveport | Louisiana | 71101 | — |
| Research Facility | Detroit | Michigan | 48202 | — |
| Research Facility | Minneapolis | Minnesota | 55404 | — |
| Research Facility | New York | New York | 10128 | — |
| Research Facility | Canton | Ohio | 44718 | — |
| Research Facility | Nashville | Tennessee | 37205 | — |
| Research Facility | San Antonio | Texas | 78215 | — |
| Research Facility | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00228449, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 20, 2012 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00228449 live on ClinicalTrials.gov.